Anthem Blue Cross Connecticut GENE.00056 Gene Expression Profiling for Bladder Cancer Form

Effective Date

12/28/2023

Last Reviewed

02/16/2023

Original Document

  Reference



This document addresses commercially available gene expression tests for the diagnosis of bladder cancer, the selection of treatment and the monitoring of individuals with a history of bladder cancer.  

Position Statement

Investigational and Not Medically Necessary:

Gene expression profiling for diagnosing, managing and monitoring bladder cancer is considered investigational and not medically necessary.